Clarify the Role of Inbrija for Parkinson's Disease

May 2019

Inbrija (in-BREE-jah) will be the first INHALED levodopa for adults with Parkinson's disease.

Think of Inbrija as a fast-acting levodopa...it starts to work in about 10 minutes and lasts about an hour. It joins the only other "on demand" option...Apokyn (apomorphine), a subcutaneous injection.

Inbrija is used as needed to treat "off" episodes...when scheduled carbidopa/levodopa wears off between doses and symptoms (rigidity, tremor, etc) return, especially as Parkinson's progresses.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Aspirin Tell Patients the Latest News About Aspirin for CV Protection
Depression Expect Spravato to Have a Limited Role for Resistant Depression
Beta-Blockers Dispel Fears About Using Beta-Blockers in Patients With COPD or Asthma
Antithrombotics Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib
Parkinson's Disease Clarify the Role of Inbrija for Parkinson's Disease
ADHD Put Psychosis Risk for ADHD Stimulants in Perspective
Dermatology Prepare Patients for Actinic Keratosis Treatment
Ophthalmology Explain How Cequa Stacks Up for Dry Eyes
Infectious Diseases Stress Adherence for Osteomyelitis Patients on Oral Antibiotics
Laws & Regulations Be Vigilant With Rxs Written by a Prescriber for Themselves or Family
Women's Health Expect Limited Use of IV Brexanolone (Zulresso) for Postpartum Depression
Communication Up Your Communication Game With "SBAR"

Clarify the Role of Inbrija for Parkinson's Disease

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents